Brief Psychological Intervention to Reduce Alcohol Consumption
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
The research aims to test the role of self-incentivising implementation intentions for reductions/abstinence of alcohol consumption among people aged 18 and over, residing in the UK, and consuming 14 units of more of alcohol at the start of the study. The effectiveness of self-incentives has been successfully seen previously within health behaviour change, has not been tested in reduction/abstinence of alcohol consumption. Therefore, this research will build on what is known about the effectiveness of self-incentives used for increasing fruit and vegetable consumption, and smoking cessation.
This study is a randomised controlled trial with the between participants factor of condition which has two levels:
1. Control (plan) or 2. Weekly self-incentivising implementation intention.
The within participants' factor will be time which has three levels:
Baseline (T1) Follow-up (T2) (1-week following baseline) Follow-up (T3) (1-month following baseline)
An ethical concern is that participants in the control condition may struggle more to reduce/abstain from alcohol consumption as they will not have the additional benefits of being within an experimental condition which uses self-incentives to aid their attempt. A control condition is needed to monitor if changes to alcohol consumption is due to the use of self-incentives or another behaviour change technique.
The recruitment process will recruit participants to complete an online questionnaire (via Qualtrics), from Prolific. Prolific is an online recruitment platform, which allows screeners to be set (e.g., age, residency, consumption level) prior to contacting potential participants. Prolific then contacts the participants to which the screeners apply, and the participants can decide if they would like to take part. The researcher can then set restrictions to only allow completion of the follow-up questionnaires, based on those participants who completed the online questionnaire at baseline.
All participants who are able to provide informed consent, are over the age of 18 years old, resident in the UK (due to discrepancies in the safe recommended alcohol consumption rates across countries), are eligible to take part in the study. Unfortunately, the study does not cater for people who cannot understand English at the present time, although this will be monitored for amendments in future studies.
The participant information sheet included prior to the online questionnaire includes details about the study, costs and benefits of taking part in the study, and the right to consent and withdraw at any point throughout the study. There are no risks involved in taking part in the study. Participants are reimbursed via Prolific based on the expected time to complete each questionnaire (i.e., £3.55 per questionnaire completed, which equates to more than the current UK living wage). There is a minimal burden in time taken to complete the questionnaires, which should take no longer than 15 minutes per time point, though this time estimation is considered generous.
In terms of confidentiality, participants will not provide any identifier other than their Prolific ID. This ensures that no identifying information is available to the research team, but that the participant can be added to the screener for completion of the baseline questionnaires, and that all questionnaires (baseline, 1-week follow-up, and 1-month follow-up) can be matched.
There are no conflicts of interest. Participants are provided with contact details of the research team, should they like to contact for a summary of the results.
Type d'étude
Type d'étude
Inscription (Réel)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Lancaster, Royaume-Uni
- Lancaster University
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Aged 18 years or over
- Able to understand written English
- Competent to provide informed consent
- Residing in the UK
- Regularly consuming 14 units of alcohol or more at baseline
Exclusion Criteria:
- Note aged 18 years old or over
- Not able to understand written English
- Not competent to provide informed consent
- Not residing in the UK
- Not regularly consuming 14 units of alcohol or more at baseline
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Behavioural: Self-incentive
Weekly self-incentivising
|
Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption).
Participants are then asked to specify a self-incentive on which they could implement at the end of each week which they have been successful.
|
|
Comparateur actif: Plan
Control
|
Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption).
Participants are then asked to form their plan.
|
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Alcohol consumption
Délai: Up to 1-month
|
Total units of alcohol consumed in last week
|
Up to 1-month
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Alcohol use disorders identification test (AUDIT)
Délai: Up to 1- month
|
Changes in AUDIT scores
|
Up to 1- month
|
|
Compliance to self-incentivise
Délai: Up to 1-month
|
Whether participants allocated to the intervention self-incentives
|
Up to 1-month
|
|
Frequency of self-incentivisation
Délai: Up to 1-month
|
How frequently participants allocated to the intervention condition use self-incentives
|
Up to 1-month
|
|
Self-incentives used
Délai: Up to 1-month
|
What self-incentives are chosen by participants (monetary, BCT etc)
|
Up to 1-month
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Réel)
Achèvement primaire
Achèvement de l'étude (Réel)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- FHM-2024-4354-RECR-4
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .